Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 11 - 01    symbols : SRDX    save search

First Round of Late-Breaking Clinical Trial Results Announced at VIVA22
Published: 2022-11-01 (Crawled : 22:00) - biospace.com/
SRDX | $26.29 -2.63% 1.6K twitter stocktwits trandingview |
Health Technology
| | O: -0.21% H: 0.76% C: -0.26%

viva22 trial results
Gainers vs Losers
41% 59%

Top 10 Gainers
TPET | $0.4801 107.75% 16M twitter stocktwits trandingview |
n/a

WISA 4 | $3.17 81.14% 36M twitter stocktwits trandingview |
Electronic Technology

PALI | $7.41 78.13% 14M twitter stocktwits trandingview |
Manufacturing

SPCB | $0.4278 55.0% 17M twitter stocktwits trandingview |
Electronic Technology

PRSO | $1.79 40.95% 25M twitter stocktwits trandingview |
Manufacturing

JAGX | $0.1668 40.4% 110M twitter stocktwits trandingview |
Health Technology

MCBC | $13.84 39.38% 450K twitter stocktwits trandingview |
Finance

SNGX | $0.5155 33.52% 3.9M twitter stocktwits trandingview |
Health Technology

SNPO | $10.57 29.85% 570K twitter stocktwits trandingview |

ITCI | $80.21 23.86% 2M twitter stocktwits trandingview |
Health Technology


Your saved searches
Save your searches and get alerts when important news are released.